Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone

Condition:   Schizophrenia Interventions:   Drug: PERSERIS;   Drug: Risperidone Sponsor:   Indivior Inc. Not yet recruiting

Source: ClinicalTrials.gov - June 7, 2019 Category: Research Source Type: clinical trials